Your Health Plan:
Not SelectedPARSABIV (etelcalcetide hydrochloride) is a brand-name prescription drug for treatment of Hyperparathyroidism, Secondary, Hyperparathyroidism and Chronic Kidney Diseases. PARSABIV is a calcium-sensing receptor agonist. It is available in the form of intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $900-4800.
Patient Assistance Prorgams are found:
Other alternatives to PARSABIV may include: